These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26625541)

  • 1. Left Cardiac Sympathetic Denervation in Patients with CASQ2-Associated Catecholaminergic Polymorphic Ventricular Tachycardia.
    Marai I; Boulos M; Khoury A
    Isr Med Assoc J; 2015 Sep; 17(9):538-40. PubMed ID: 26625541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia.
    Khoury A; Marai I; Suleiman M; Blich M; Lorber A; Gepstein L; Boulos M
    Heart Rhythm; 2013 Nov; 10(11):1671-5. PubMed ID: 23954267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome.
    Schneider HE; Steinmetz M; Krause U; Kriebel T; Ruschewski W; Paul T
    Clin Res Cardiol; 2013 Jan; 102(1):33-42. PubMed ID: 22821214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation.
    De Ferrari GM; Dusi V; Spazzolini C; Bos JM; Abrams DJ; Berul CI; Crotti L; Davis AM; Eldar M; Kharlap M; Khoury A; Krahn AD; Leenhardt A; Moir CR; Odero A; Olde Nordkamp L; Paul T; Rosés I Noguer F; Shkolnikova M; Till J; Wilde AA; Ackerman MJ; Schwartz PJ
    Circulation; 2015 Jun; 131(25):2185-93. PubMed ID: 26019152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia.
    Gray B; Bagnall RD; Lam L; Ingles J; Turner C; Haan E; Davis A; Yang PC; Clancy CE; Sy RW; Semsarian C
    Heart Rhythm; 2016 Aug; 13(8):1652-60. PubMed ID: 27157848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical and Psychological Consequences of Left Cardiac Sympathetic Denervation in Long-QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia.
    Waddell-Smith KE; Ertresvaag KN; Li J; Chaudhuri K; Crawford JR; Hamill JK; Haydock D; Skinner JR;
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1151-8. PubMed ID: 26224781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left thoracoscopic sympathectomy for cardiac denervation in patients with life-threatening ventricular arrhythmias.
    Hofferberth SC; Cecchin F; Loberman D; Fynn-Thompson F
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):404-9. PubMed ID: 24268954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for the diagnosis and management of Catecholaminergic Polymorphic Ventricular Tachycardia.
    Pflaumer A; Davis AM
    Heart Lung Circ; 2012 Feb; 21(2):96-100. PubMed ID: 22119737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism underlying catecholaminergic polymorphic ventricular tachycardia and approaches to therapy.
    Watanabe H; Knollmann BC
    J Electrocardiol; 2011; 44(6):650-5. PubMed ID: 21872879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catecholaminergic polymorphic ventricular tachycardia.
    Liu N; Ruan Y; Priori SG
    Prog Cardiovasc Dis; 2008; 51(1):23-30. PubMed ID: 18634915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound heterozygous CASQ2 mutations and long-term course of catecholaminergic polymorphic ventricular tachycardia.
    Josephs K; Patel K; Janson CM; Montagna C; McDonald TV
    Mol Genet Genomic Med; 2017 Nov; 5(6):788-794. PubMed ID: 29178653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha blockade potentiates CPVT therapy in calsequestrin-mutant mice.
    Kurtzwald-Josefson E; Hochhauser E; Bogachenko K; Harun-Khun S; Katz G; Aravot D; Seidman JG; Seidman CE; Eldar M; Shainberg A; Arad M
    Heart Rhythm; 2014 Aug; 11(8):1471-9. PubMed ID: 24768611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Video-Assisted Thoracoscopic Left Cardiac Sympathetic Denervation in Patients with Hereditary Ventricular Arrhythmias.
    Jang SY; Cho Y; Kim NK; Kim CY; Sohn J; Roh JH; Bae MH; Lee JH; Yang DH; Park HS; Chae SC; Oh TH; Kim GJ
    Pacing Clin Electrophysiol; 2017 Mar; 40(3):232-241. PubMed ID: 28012188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetics of exercise-induced polymorphic ventricular tachycardia: identification of three novel cardiac ryanodine receptor mutations and two common calsequestrin 2 amino-acid polymorphisms.
    Laitinen PJ; Swan H; Kontula K
    Eur J Hum Genet; 2003 Nov; 11(11):888-91. PubMed ID: 14571276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of catecholaminergic polymorphic ventricular tachycardia caused by two calsequestrin 2 mutations.
    de la Fuente S; Van Langen IM; Postma AV; Bikker H; Meijer A
    Pacing Clin Electrophysiol; 2008 Jul; 31(7):916-9. PubMed ID: 18684293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left cardiac sympathetic denervation in the management of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: A meta-regression.
    Sgrò A; Drake TM; Lopez-Ayala P; Phan K
    Congenit Heart Dis; 2019 Nov; 14(6):1102-1112. PubMed ID: 31621201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery.
    Collura CA; Johnson JN; Moir C; Ackerman MJ
    Heart Rhythm; 2009 Jun; 6(6):752-9. PubMed ID: 19467503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular adaptation to calsequestrin 2 (CASQ2) point mutations leading to catecholaminergic polymorphic ventricular tachycardia (CPVT): comparative analysis of R33Q and D307H mutants.
    Valle G; Arad M; Volpe P
    J Muscle Res Cell Motil; 2020 Sep; 41(2-3):251-258. PubMed ID: 32902830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the first induced pluripotent stem cell line generated from a patient with autosomal dominant catecholaminergic polymorphic ventricular tachycardia due to a heterozygous mutation in cardiac calsequestrin-2.
    Ross S; Holliday M; Lim S; Semsarian C
    Stem Cell Res; 2019 May; 37():101450. PubMed ID: 31039485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening.
    Haugaa KH; Leren IS; Berge KE; Bathen J; Loennechen JP; Anfinsen OG; Früh A; Edvardsen T; Kongsgård E; Leren TP; Amlie JP
    Europace; 2010 Mar; 12(3):417-23. PubMed ID: 20106799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.